Tesla
TSLA
MicroStrategy
MSTR
MARA Holdings
MARA
Apple
AAPL
Microsoft
MSFT
US Stock MarketDetailed Quotes
IPHA Innate Pharma
- 3.020
- +1.470+94.84%
Close Dec 13 16:00 ET
- 3.000
- -0.020-0.66%
Post 19:59 ET
250.01MMarket Cap-6.86P/E (TTM)
3.511High1.470Low13.59MVolume1.500Open1.550Pre Close34.51MTurnover23.81%Turnover RatioLossP/E (Static)82.78MShares3.51152wk High8.30P/B172.40MFloat Cap1.29052wk Low--Dividend TTM57.09MShs Float11.950Historical High--Div YieldTTM131.66%Amplitude1.290Historical Low2.539Avg Price1Lot Size
Innate Pharma Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | (FY)Dec 31, 2018 | (FY)Dec 31, 2017 | (FY)Dec 31, 2016 | (FY)Dec 31, 2015 | (FY)Dec 31, 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 4.68%51.9M | 309.41%49.58M | -78.43%12.11M | -18.15%56.16M | -14.12%68.61M | 144.83%79.89M | -41.90%32.63M | 213.64%56.16M | 1,874.20%17.91M | -92.73%907K |
| Operating revenue | 3.37%51.89M | 314.51%50.2M | -78.59%12.11M | -17.18%56.57M | -14.00%68.31M | 145.53%79.42M | -42.52%32.35M | 214.58%56.27M | 1,872.22%17.89M | -92.73%907K |
| Cost of revenue | -99.21%337K | 42.74M | 0 | 0 | 0 | |||||
| Gross profit | 886.82%79.56M | -118.00%-10.11M | 213.64%56.16M | 1,874.20%17.91M | -81.45%907K | |||||
| Operating expense | -2.17%64.57M | 10.12%66.01M | 8.83%59.94M | -17.84%55.08M | -9.91%67.04M | 149.10%74.41M | -38.52%29.87M | 69.42%48.59M | 37.39%28.68M | 172.40%20.87M |
| Selling and administrative expenses | -18.83%11.75M | -9.49%14.47M | 26.00%15.99M | -14.15%12.69M | -18.87%14.78M | -45.91%18.22M | 261.07%33.68M | 58.71%9.33M | 22.53%5.88M | -55.03%4.8M |
| -Selling and marketing expense | ---- | ---- | ---- | ---- | ---- | 132.36%1.51M | 44.22%649K | 56.25%450K | 11.20%288K | -8.48%259K |
| -General and administrative expense | -18.83%11.75M | -9.49%14.47M | 26.00%15.99M | -14.15%12.69M | -11.55%14.78M | -49.41%16.71M | 272.06%33.04M | 58.84%8.88M | 23.18%5.59M | -56.30%4.54M |
| Research and development costs | 8.44%56.02M | 9.91%51.66M | -5.44%47M | -20.97%49.71M | -9.57%62.9M | 2,078.36%69.56M | -93.43%3.19M | 62.60%48.63M | 31.91%29.91M | --22.67M |
| Depreciation amortization depletion | ---- | ---- | ---- | ---- | ---- | -84.24%693K | 2,177.72%4.4M | 48.46%193K | 7.44%130K | -86.25%121K |
| -Depreciation and amortization | ---- | ---- | ---- | ---- | ---- | -84.24%693K | 2,177.72%4.4M | 48.46%193K | 7.44%130K | -86.25%121K |
| Other operating expenses | -2,342.75%-3.2M | 95.72%-131K | 58.24%-3.06M | 31.21%-7.32M | 24.29%-10.65M | -23.31%-14.06M | -19.26%-11.4M | -32.15%-9.56M | -7.74%-7.24M | -64.14%-6.72M |
| Operating profit | 22.87%-12.67M | 65.66%-16.43M | -4,532.53%-47.83M | -31.40%1.08M | -69.43%1.57M | 112.87%5.15M | -628.09%-39.98M | 170.28%7.57M | 46.05%-10.77M | -620.05%-19.97M |
| Net non-operating interest income expense | 883.33%2.54M | 1,620.00%258K | -93.27%15K | -84.44%223K | 10.40%1.43M | 20.07%1.3M | 57.58%1.08M | 712.50%686K | 45.10%-112K | 22.43%-204K |
| Non-operating interest income | 481.87%3.18M | 66.97%546K | -42.02%327K | -65.19%564K | 2.40%1.62M | 26.16%1.58M | --1.25M | ---- | ---- | ---- |
| Non-operating interest expense | 122.22%640K | -7.69%288K | -8.50%312K | 67.16%341K | 100.00%204K | -9.73%102K | -8.87%113K | -10.79%124K | -15.76%139K | -14.95%165K |
| Total other finance cost | ---- | ---- | ---- | ---- | -109.34%-17K | 203.33%182K | 107.41%60K | -2,900.00%-810K | -169.23%-27K | -43.48%39K |
| Other net income (expense) | 106.13%2.56M | -1,894.21%-41.81M | 209.34%2.33M | -143.86%-2.13M | 230.44%4.86M | 59.13%-3.73M | -294.60%-9.12M | 12.11%4.68M | 698.85%4.18M | 263.19%523K |
| Gain on sale of security | 418.26%2.56M | -134.55%-805K | 209.34%2.33M | -143.86%-2.13M | 230.44%4.86M | 59.13%-3.73M | -294.60%-9.12M | 12.11%4.68M | 486.80%4.18M | 81.63%712K |
| Earnings from equity interest | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 22.86%-189K |
| Special income (charges) | --0 | ---41M | --0 | --0 | ---- | --0 | ---- | ---- | ---- | ---- |
| -Less:Impairment of capital assets | --0 | --41M | --0 | --0 | ---- | --0 | ---- | ---- | ---- | ---- |
| Income before tax | 86.94%-7.57M | -27.47%-57.97M | -5,385.89%-45.48M | -110.54%-829K | 189.48%7.87M | 105.66%2.72M | -471.04%-48.02M | 292.98%12.94M | 65.87%-6.71M | -579.36%-19.65M |
| Income tax | 0 | 0 | 0 | 0 | 0 | -190.49%-333K | 22.26%368K | 301K | 0 | 0 |
| Net income | 86.97%-7.57M | -10.02%-58.1M | 17.47%-52.81M | -208.22%-63.98M | -780.85%-20.76M | 106.30%3.05M | -482.79%-48.39M | 288.49%12.64M | 65.87%-6.71M | -579.36%-19.65M |
| Net income continuous Operations | 86.94%-7.57M | -27.47%-57.97M | -5,385.89%-45.48M | -110.54%-829K | 158.05%7.87M | 106.30%3.05M | -482.79%-48.39M | 288.49%12.64M | 65.87%-6.71M | -579.36%-19.65M |
| Net income discontinuous operations | --0 | 98.21%-131K | 88.39%-7.33M | -120.61%-63.16M | ---28.63M | ---- | ---- | ---- | ---- | ---- |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 86.97%-7.57M | -10.02%-58.1M | 17.47%-52.81M | -208.22%-63.98M | -780.85%-20.76M | 106.30%3.05M | -482.79%-48.39M | 288.49%12.64M | 65.87%-6.71M | -579.36%-19.65M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 86.97%-7.57M | -10.02%-58.1M | 17.47%-52.81M | -208.22%-63.98M | -780.85%-20.76M | 106.30%3.05M | -482.79%-48.39M | 288.49%12.64M | 65.87%-6.71M | -579.36%-19.65M |
| Basic earnings per share | 87.67%-0.09 | -10.61%-0.73 | 18.52%-0.66 | -161.29%-0.81 | -720.00%-0.31 | 105.62%0.05 | -486.96%-0.89 | 276.92%0.23 | 66.67%-0.13 | -457.14%-0.39 |
| Diluted earnings per share | 87.67%-0.09 | -10.61%-0.73 | 18.52%-0.66 | -161.29%-0.81 | -720.00%-0.31 | 105.62%0.05 | -486.96%-0.89 | 276.92%0.23 | 66.67%-0.13 | -457.14%-0.39 |
| Dividend per share | ||||||||||
| Currency Unit | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
